Y. Niijima

发表

Elevated 1‐h plasma glucose following 75‐g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance

M. Yamada, K. Niijima, Y. Muranaka, 2012, Diabetic medicine : a journal of the British Diabetic Association.

24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study.

K. Kario, T. Katsuya, Mitsutoshi Kato, 2018, Circulation.

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

K. Kario, T. Katsuya, Mitsutoshi Kato, 2018, Circulation.

Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM

Tsugumichi Saito, S. Okada, Yasuyo Nakajima, 2019, Diabetes Therapy.

Renal threshold for glucose reabsorption predicts diabetes improvement by sodium‐glucose cotransporter 2 inhibitor therapy

Tsugumichi Saito, S. Okada, M. Yamada, 2016, Journal of diabetes investigation.

Effect of a Novel Calcium Channel Blocker on Abnormal Nocturnal Blood Pressure in Hypertensive Patients

K. Kario, S. Takiuchi, S. Ando, 2013, Journal of clinical hypertension.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Is Dipeptidyl Peptidase-4 Inhibitor a Risk Factor to Develop Permanent Hypo- thyroidism in Subacute Thyroiditis in Patients with Type 2 Diabetes Mellitus?

Tsugumichi Saito, Yasuyo Nakajima, M. Yamada, 2020 .

Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.

S. Okada, M. Yamada, K. Niijima, 2017, Annals of hepatology.

Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance

Tsugumichi Saito, S. Okada, M. Yamada, 2016, Adipocyte.

Interstitial pneumonia during administration of dipeptidyl peptidase‐4 inhibitors

S. Okada, M. Yamada, Yuko Tagaya, 2015, Journal of diabetes.

High risk of KL‐6 elevation when DPP‐4 inhibitors and amiodarone are prescribed simultaneously

Tsugumichi Saito, S. Okada, Yasuyo Nakajima, 2019, Practical Diabetes.

Metformin administration attenuates dipeptidyl peptidase‐4 inhibitor‐induced increases in Krebs von den Lungen‐6 (KL‐6) levels

S. Okada, M. Yamada, Eijiro Yamada, 2018, Journal of diabetes.

Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early‐stage atherosclerosis

M. Yamada, T. Ando, S. Okada, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.

S. Okada, M. Yamada, K. Niijima, 2017, Annals of hepatology.